Atea Pharmaceuticals, Inc.

AVIR - CIK 0001593899

Market cap-

Rank-

SEC filings301

Atea Pharmaceuticals, Inc. revenue by year

Atea Pharmaceuticals, Inc. (AVIR) reported revenue of $351.37M for fiscal year 2021, as filed in its audited annual report with the SEC.

AVIR annual revenue

Fiscal year	Revenue	Change
FY 2021	$351.37M	+622.5%
FY 2020	$48.63M	-

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.